Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov and opm.gov for updates. The page revision has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check11 days agoChange DetectedShow glossary functionality was added to the page and several metadata labels were updated (including Last Update Posted and Revision: v3.4.0). Some QC-related field labels were reworded (e.g., Last Update Submitted that Met QC Criteria).SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive changes to study details or layout.SummaryDifference0.1%

- Check32 days agoChange DetectedStudy timeline dates were updated with new milestones added (e.g., 2025-12-30, 2026-04-30, 2025-12-28, 2025-12) and some earlier milestones removed (e.g., 2025-09-23, 2025-12-31, 2025-09-17, 2025-09).SummaryDifference0.3%

- Check47 days agoChange DetectedAdded a Locations section listing Missouri and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the Missouri Locations header (older revision).SummaryDifference0.2%

- Check75 days agoChange DetectedPublications section wording was updated to indicate entries are automatically filled from PubMed and may not all pertain to the study; the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.